New York, NY (PRWEB) November 04, 2013
Peter R. Dottino, MD, has been appointed Director of the Division of Gynecologic Oncology in the Department of Obstetrics, Gynecology and Reproductive Medicine at the Mount Sinai Health System, effective October 1, 2013. He also holds an appointment as Associate Clinical Professor at the Icahn School of Medicine at Mount Sinai.
Dr. Dottino is an internationally-renowned expert in operative laparoscopy and its application to the surgical management of gynecologic cancers, such as ovarian, fallopian tube, vaginal, and cervical cancers. He is currently Director of the Group for Women and Co-Director with John A. Martignetti, MD, of the Ovarian Cancer Translational Research Laboratory at Mount Sinai, a genomic research program dedicated to uncovering the genetic basis of ovarian cancer.
Dr. Dottino previously served as the Director of Gynecologic Oncology at Mount Sinai and also is one of the founders of the Ovarian Cancer Research Fund, the oldest and largest charity in the United States funding ovarian cancer research, and of the Woman to Woman Program at Mount Sinai. It provides survivor-led support to women with gynecologic cancer and their families.
He currently serves on the Board as Vice President of Woman to Woman, an organization addressing the cancer needs of women globally. Along with Drs. Dottino and Segna, Dr. Beddoe cofounded Woman to Woman.
Dr. Dottino’s partners, Rudy Albert Segna, MD, the new Associate Director of Gynecologic Oncology, and Ann Marie Beddoe, MD, the new Director of the Gynecologic Oncology Chemotherapy Infusion Service, will join him here as fulltime faculty members. All three are prolific researchers who have published in many medical journals, and actively lectured nationally and internationally.
“I am pleased that Drs. Dottino, Segna and Beddoe will lead the division of gynecologic oncology,” said Michael Brodman,
Copyright©2012 Vocus, Inc.
All rights reserved